If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

17 Jan 2008 07:01

Amphion Innovations PLC17 January 2008 Amphion Innovations plc Trading Update 17 January 2008 - Amphion Innovations plc (LSE: AMP) ('Amphion' or the'Company'), is pleased to announce that results for the 12 month period to 31December 2007 are expected to show an increase in Net Asset Value per Share of29% to $0.44 (£0.22), broadly in line with market expectations. Profit beforeTax is expected to be approximately $10.5 million, a 50% increase from theprevious year, primarily reflecting the uplift in the value of the investments. Amphion builds shareholder value in high growth companies in the medical andtechnology sectors, by using a focused, hands-on company building approach,based on decades of experience in both the US and UK. Currently there are 10Partner Companies developing proven technologies targeting substantialcommercial marketplaces, in excess of $1 billion. Each Partner Company aims toachieve a target exit value in excess of $100 million supported by Amphionmanagement team's strong track record of delivering liquidity events. During 2007, Amphion successfully helped its Partner Companies raise over $21million. Looking ahead, the Company expects to build on the substantial progress made in2007. Following a successful fundraising, WellGen is in a strong position tomeet its commercial objectives in 2008, having raised $9.5 million in October2007. Durham Scientific Crystals is also well placed following the signing of acontract with the UK Home Office in December 2007. The contract is to developits groundbreaking technology for digital x-ray imaging for use in both medicalapplications and airport security scanners to detect explosives and flammablematerial. Amphion is pleased to report that its Gulf based joint venture, MSA, has beenfully incorporated and capitalized. This will enable it to move forward with thecompany's business plan and to develop strategic partnerships for Amphion andits Partner Companies in the Gulf region. During 2007 Amphion continued to develop its two new Partner Companies, EnergyTrading International ('ETI') and DataTern Inc. ETI seeks to exploit the trendtowards automation of markets through the development of a proprietary(patented) platform for the automatic negotiation and execution of bilateral,structured trades. DataTern Inc. is being formed to develop and extract valuefrom the substantial and growing patented portfolio in Amphion's PartnerCompanies. The Company estimates that its Partner Companies have over 150individual pieces of intellectual property, double the amount at the time oflisting in August 2005. Amphion expects to announce its preliminary results for the 12 months to 31December 2007, in March 2008. Richard C.E. Morgan, Amphion's Chief Executive Officer, said: "During 2007,Amphion and our Partner Companies achieved several key milestones. We arefocused on creating shareholder value, and given the strength of our PartnerCompanies, we are very confident of being able to continue to deliver furthergrowth." For further information please contact: Amphion InnovationsCharlie Morgan:+1 (212) 210-6224 Cardew GroupTim Robertson/ Jamie Milton/Matthew Law:+44 020 7930 0777 Charles Stanley Securities, Nominated AdvisorMark Taylor/ Freddy Crossley:+44 020 7149 6000 On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update
21st Aug 20187:15 amRNSMotif Bio notes statement from Amphion Innovations
21st Aug 20187:00 amRNSSale of Partner Company Shares
1st Aug 20184:47 pmRNSResult of AGM
29th Jun 20187:00 amRNSDirectorate Change
26th Jun 20187:00 amRNSFinal Results
23rd May 20187:00 amRNSMotif Bio notes statement from Amphion Innovations
23rd May 20187:00 amRNSSale of Partner Company Shares
20th Apr 20187:00 amRNSDirectorate Change
29th Mar 20187:00 amRNSAIM Admission & First Day of Dealings
29th Mar 20187:00 amRNSUpdate on Polarean Imaging IPO
26th Mar 20187:31 amRNSUpdate on Polarean Imaging proposed AIM IPO
2nd Mar 20187:00 amRNSConvertible promissory note extended to December
10th Jan 20185:09 pmRNSDirector dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.